Rein Therapeutics Stock Alpha and Beta Analysis
| RNTX Stock | 1.14 0.10 8.06% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Rein Therapeutics. It also helps investors analyze the systematic and unsystematic risks associated with investing in Rein Therapeutics over a specified time horizon. Remember, high Rein Therapeutics' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Rein Therapeutics' market risk premium analysis include:
Beta 0.57 | Alpha 0.2 | Risk 6.5 | Sharpe Ratio 0.0226 | Expected Return 0.15 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Check out Rein Therapeutics Backtesting, Rein Therapeutics Valuation, Rein Therapeutics Correlation, Rein Therapeutics Hype Analysis, Rein Therapeutics Volatility, Rein Therapeutics History and analyze Rein Therapeutics Performance. Rein Therapeutics Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Rein Therapeutics market risk premium is the additional return an investor will receive from holding Rein Therapeutics long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Rein Therapeutics. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Rein Therapeutics' performance over market.| α | 0.20 | β | 0.57 |
Rein Therapeutics expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Rein Therapeutics' Buy-and-hold return. Our buy-and-hold chart shows how Rein Therapeutics performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Rein Therapeutics Market Price Analysis
Market price analysis indicators help investors to evaluate how Rein Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Rein Therapeutics shares will generate the highest return on investment. By understating and applying Rein Therapeutics stock market price indicators, traders can identify Rein Therapeutics position entry and exit signals to maximize returns.
Rein Therapeutics Return and Market Media
The median price of Rein Therapeutics for the period between Wed, Oct 1, 2025 and Tue, Dec 30, 2025 is 1.37 with a coefficient of variation of 9.98. The daily time series for the period is distributed with a sample standard deviation of 0.14, arithmetic mean of 1.37, and mean deviation of 0.11. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Acquisition by Voss Capital, Lp of 30176 shares of Rein Therapeutics at 1.3904 subject to Rule 16b-3 | 10/24/2025 |
2 | Acquisition by Voss Capital, Lp of 4840 shares of Rein Therapeutics at 1.3687 subject to Rule 16b-3 | 10/27/2025 |
3 | Why retail investors pile into Rein Therapeutics Inc. stock - 2025 Breakouts Breakdowns Weekly Chart Analysis and Trade Guides - newser.com | 10/30/2025 |
4 | Why Is Rein Therapeutics Stock Trading Higher On Monday | 11/03/2025 |
5 | Acquisition by Voss Capital, Lp of 104183 shares of Rein Therapeutics at 1.2247 subject to Rule 16b-3 | 11/14/2025 |
6 | Will Rein Therapeutics Inc. stock gain from strong economy - Earnings Recap Report Fast Gaining Stock Reports - newser.com | 11/17/2025 |
7 | Rein Therapeutics Inc. Stock Price Live Quotes Charts NASDAQ - StocksToTrade | 11/25/2025 |
8 | Rein Therapeutics Ends Key Financial Agreements - TipRanks | 12/11/2025 |
About Rein Therapeutics Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Rein or other stocks. Alpha measures the amount that position in Rein Therapeutics has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2024 | 2025 (projected) | PB Ratio | 7.59E-4 | 7.21E-4 | Capex To Depreciation | 1.49 | 1.42 |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Rein Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Rein Therapeutics' short interest history, or implied volatility extrapolated from Rein Therapeutics options trading.
Build Portfolio with Rein Therapeutics
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Tools for Rein Stock Analysis
When running Rein Therapeutics' price analysis, check to measure Rein Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rein Therapeutics is operating at the current time. Most of Rein Therapeutics' value examination focuses on studying past and present price action to predict the probability of Rein Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rein Therapeutics' price. Additionally, you may evaluate how the addition of Rein Therapeutics to your portfolios can decrease your overall portfolio volatility.